Abstract
Neurological complications are highly prevalent in CKD. These complications can potentially affect all levels of the nervous system from central nervous system disorders such as cognitive dysfunction and encephalopathy, to peripheral disorders such as myopathy, autonomic and peripheral neuropathies. These conditions have a significant impact not only causing morbidity due to pain, weakness, reduced exercise capacity, and disability but also increased mortality risk. Management strategies for peripheral neuropathy include pharmacological treatment of painful symptoms, while dietary potassium restriction, glycaemic control, and exercise strategies may be beneficial. Uremic myopathy may respond to exercise programs, adequate nutritional intake, and treatment with erythropoietin. Treatment of carpal tunnel syndrome with wrist splints or corticosteroid injections may provide benefit. Patients with autonomic neuropathy may respond to sildenafil for impotence. Cognitive dysfunction and dementia may be assessed using the Montreal cognitive examination or the mini-mental state examination and should be differentiated from encephalopathy which is accompanied by tremor and asterixis. Early detection and management of chronic neurological conditions provides a window of opportunity to reduce their impact at later stages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Arnold R, et al. Peripheral neuropathy: an important contributor to physical limitation and morbidity in stages 3 and 4 chronic kidney disease. Nephrol Dial Transplant. 2022;37(4):713–9.
Issar T, et al. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients. Clin Neurophysiol. 2019;130(11):2088–95.
Krishnan AV, Pussell BA, Kiernan MC. Neuromuscular disease in the dialysis patient: an update for the nephrologist. Semin Dial. 2009;22(3):267–78.
Pop-Busui R, et al. The management of diabetic neuropathy in CKD. Am J Kidney Dis. 2010;55(2):365–85.
Hu N, Niu J, Liu M. Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy. Neurol Sci. 2022;43:5885.
Arnold R, et al. Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD. Clin J Am Soc Nephrol. 2017;12(10):1569–77.
Jensen TS, et al. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain. 2021;144(6):1632–45.
Bonnet J-B, Sultan A. Narrative review of the relationship between CKD and diabetic foot ulcer. Kidney Int Rep. 2022;7(3):381–8.
Krishnan AV, Kiernan MC. Neurological complications of chronic kidney disease. Nat Rev Neurol. 2009;5(10):542–51.
Kang A, et al. Effect of Hemodiafiltration on the progression of neuropathy with Kidney failure: a randomized controlled trial. Clin J Am Soc Nephrol. 2021;16(9):1365–75.
Arnold R, et al. Association between Calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. Am J Transplant. 2013;13(9):2426–32.
Salman IM. Cardiovascular autonomic dysfunction in chronic Kidney disease: a comprehensive review. Curr Hypertens Rep. 2015;17(8):59.
National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
Soomro QH, Charytan DM. Cardiovascular autonomic nervous system dysfunction in chronic kidney disease and end-stage kidney disease: disruption of the complementary forces. Curr Opin Nephrol Hypertens. 2021;30(2):198–207.
Papadopoulou E, et al. Erectile dysfunction in chronic kidney disease: from pathophysiology to management. World J Nephrol. 2015;4(3):379–87.
Kanbay M, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981–93.
Gousheh J, Iranpour A. Association between carpel tunnel syndrome and arteriovenous fistula in hemodialysis patients. Plast Reconstr Surg. 2005;116(2):508–13.
Clyne N. Physical working capacity in uremic patients. Scand J Urol Nephrol. 1996;30(4):247–52.
Campistol JM. Uremic myopathy. Kidney Int. 2002;62(5):1901–13.
Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial. 2008;21(1):29–37.
Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74(6):782–90.
McQuillan R, Jassal SV. Neuropsychiatric complications of chronic kidney disease. Nat Rev Nephrol. 2010;6(8):471–9.
Viggiano D, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020;16(8):452–69.
Kelly DM, Rothwell PM. Disentangling the relationship between chronic kidney disease and cognitive disorders. Front Neurol. 2022;13:830064.
Pepin M, et al. Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment. Nephrol Dial Transplant. 2021;37(Suppl 2):ii23–32.
Puy L, et al. Cognitive impairments and Dysexecutive behavioral disorders in chronic Kidney disease. J Neuropsychiatry Clin Neurosci. 2018;30(4):310–7.
Williamson JD, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–61.
Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011;31(2):139–43.
Van Dijck A, Van Daele W, De Deyn PP. In: Tanasescu R, editor. Uremic encephalopathy, in miscellanea on encephalopathies—a second look. London: InTech; 2012. p. 23–38.
Titoff V, et al. Seizures, antiepileptic drugs, and CKD. Am J Kidney Dis. 2019;73(1):90–101.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Arnold, R., Krishnan, A.V. (2023). Neuropathy and Other Neurological Problems in Chronic Kidney Disease. In: Arıcı, M. (eds) Management of Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-031-42045-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-031-42045-0_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-42044-3
Online ISBN: 978-3-031-42045-0
eBook Packages: MedicineMedicine (R0)